KMC Speciality Hospitals (India) Ltd — Important, 05-06-2026: Company Update
5th June, 2026
To
BSE Limited
Corporate Relationship Department
P J Towers,
Dalal Street, Fort
Mumbai – 400 001.
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 – Investor Presentation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
we enclose herewith the Investor Presentation for the quarter and year ended 31st March, 2026. The
same will also be available on the website of the Company.
This is for your kind information and records.
Thanking You
Yours faithfully,
For KMC SPECIALITY HOSPITALS (INDIA) LIMITED
Indumathi P
Company Secretary & Compliance Officer
----------------Page (0) Break----------------
Making great healthcare affordable
INVESTOR
PRESENTATION
Q4 FY’2026
KMC SPECIALITY HOSPITALS (INDIA) LTD
----------------Page (1) Break----------------
Contents
ABOUT US
HOSPITAL OVERVIEW
SUSTAINABLE GROWTH STRATEGY
MAJOR EVENTS
LEADERSHIP TEAM
3
5
6
7
9
2
BOARD OF DIRECTORS11
FY’2026 PERFORMANCE SUMMARY
HISTORICAL FINANCIAL PERFORMANCE
12
24
----------------Page (2) Break----------------
ABOUT US
3
----------------Page (3) Break----------------
•KMC Speciality Hospitals (India) Limited operates a 450-
bedded Multi-Specialty Hospital at Trichy, a major city in
the State of Tamil Nadu
•The Hospital focusses on providing Multi-Specialty services
focused on:
•Mother & Child Care Services;
•Neurosciences;
•Gastro Sciences;
•Orthopedics;
•Plastic surgeries;
•Organ Transplants (Liver & Bone Marrow Transplant);
•Critical care;
•The Hospital facilities are centrally located and draws
patients from over 200 kilometers for Neonatal, Pediatrics,
Neuro and Gastro sciences and other tertiary care services.
•Further, we operationalised our new facility comprising of
200 beds focused on providing Mother and Child Care
services from January 29, 2024.
About us
4
----------------Page (4) Break----------------
Hospital Overview : Key Specialities and Advanced Infrastructure
2Healthcare Facilities Operational Beds
1 Existing Facility 250 Beds
1New Facility (Maa Kauvery) 200 Beds
Orthopaedics
Critical Care
Bone Marrow Transplant
Liver Transplant
Full-timeemployeesand
Associatesincluding170Doctors
1700+
5
Mother & Child Care
Neuro Science
Gastro Science
Plastic Surgery
Centre of Excellence
Well equipped with Advanced Infrastructure
OT Theatres (Incl. Labour OT)
ICU’s (Incl. PICU, NICU etc)
CT
MRI
Mammogram
Ventilators
Dexa Scan
Lab
Tiruchirapalli
45%
Pudukkottai
Thanjavur
9%
10%
Perambalur
5%
Thiruvarur
4%
Nagapattinam
4%Karur3%
Cuddalore
5%
Our catchment area
Ariyalur
6%
~89% of IP comes from various cities in and around Tiruchirapalli as represented above
----------------Page (5) Break----------------
Quality / Digital Enablement
Capacity Expansion
Doctors Engagement Model
Centers of Excellence
Cutting Edge Technology
Legacy block: 250 Beds
G+6F+1B
New Block: 200 Beds
G+5F+2B
Identifying, attracting and
retaining right Clinical
talent resulting in better
clinical outcomes
•Focus on Specialties
and growth of
programs
•Academic
enablement with
currently over 44
DnB,Diploma seats
Stay up-to date on
technological advancement
for better patient experience
and clinical results.
•NABHaccreditedHospital
•Nursingexcellence
•Pioneersinadopting5S-
WorkplaceOrganization
MethodinHospitalSector
backedbyaStrongDigital
ecosystem
Sustainable Growth Strategy
6
----------------Page (6) Break----------------
642
2008
20132024
20152023
2022
Major Events
SriKauveryMedicalCare
(India)LtdacquiredKMC
SpecialityHospitalsIndiaLtd
inOct’2008with250beds
Started:
PaediatricsDepartment
Started:
NeuroScienceDepartment
ActivatedTransplantProgram:
Completed97+BoneMarrow
Transplants;
44+LiverTransplantssofar......
ConsistentFinancial
performancewith22%
CAGRandreachinga
milestoneofINR158Cr
inRevenuesandEBITDA
of28.0%
AnnouncedOperationalising
NewHospitalof200Beds
withfocusonMother&
Childcare
7
----------------Page (7) Break----------------
TheGroupwasfounded25yearsagoandcurrentlyoperates12Multi-SpecialityHospitalshavingover2,500
bedsincapacityacrossChennai,Trichy,Bengaluru,Salem,HosurandTirunelveli;
10oftheHospitalsaredirectlyrunintheParententity;
TheParententityowns75%ofitslistedsubsidiary,KMCSpecialityHospitals(India)Ltdandruns2Hospitals
withcombinedcapacityof450Beds.(Legacyblock:250BedsandNewblock:200Beds);
TheGroupispromotedbyDr.SChandrakumarandDr.SManivannanandhasmarqueeprivateequity/
financialInvestorsasitsshareholders.
Sri Kauvery Medical Care (India) Limited (“The Group / The Parent”)
8
----------------Page (8) Break----------------
Dr. S. Chandrakumar
Founder & Executive Chairman
Dr. S. Manivannan
Founder & Managing Director
Dr. D. Senguttuvan
SBU Head –Co-Founder, Executive Director
& Key Managerial Person
•Aqualifiedandexperienced
anesthesiologistandcriticalcare
specialistwith20+yearsofexperience;
•FormerChairmanofCIITNState
Council(FY2021-22);
•LifeMemberinIndianSocietyof
Anaesthesiologists&CriticalCare
Medicine.
QualifiedAnesthesiologistwith20+yearsof
clinicalexperience;
OutstandingAnaesthesiologistfor2010
(IndianSocietyofAnesthesiology);
LeadingMedicalEntrepreneur2018by
IndianMedicalAssociation;
CertifiedAssessorinNABH(National
AccreditationBoardforHospitals&
Healthcare);
FounderofIndia’slargestmedical
equipmentexpo–MEDICALL.
SBU head of KMC Specialty Hospitals (India)
Limited;
A Leader in Advanced Paediatric Care and
Healthcare Excellence in Tamil Nadu;
Chief Pediatrician with over 3 decades of Clinical
expertise;
Past Secretary –IAP (2008-2010);
Former Healthcare Convener in CII (FY 2016-17);
Chairman –CII Trichy Zone (FY 2021-22);
Founder President of NNF, Trichy chapter.
Leadership Team
9
----------------Page (9) Break----------------
Our vision, mission and values
10
' I , <®>
, I '
\ I I 5)
Our Vision
To be the most respected andl trusted healthoare
provider
To make great healthcare affordable
O rVa ues
• Cont'in~a~ I pirovemeri .
• ea tf elt Perao ria 11 ouch•
• Et icat
• E ·• pat ·e ic Caire ..
• Rea I Acco u n albH ity;.
• Seirv1ce Excellence.
kauvery
hospital
----------------Page (10) Break----------------
Board of Directors
DrSChandrakumar(ExecutiveChairman)isapassionate
leader,withover20+yearsofreputedclinicalexperience
andmanagingMultiSpecialityhospitals.Heisoneofthe
PromotersofSriKauveryMedicalCare(India)Limited.
DrSManivannan(ManagingDirector)isan
Anaesthesiologist,withover20+yearsofreputedclinical
experienceandmanagingMultiSpecialityhospitals.Heis
oneofthePromotersofSriKauveryMedicalCare(India)
Limited.HeisalsothefounderofMEDICALL,India’slargest
MedicalEquipmentExhibition
DrTSenthilkumarM.S.,M.Ch.,(Non-ExecutiveDirector)isa
seniorconsultantCardiothoracicSurgeonwithover2decades
ofprofessionalexperience.Hewasinstrumentalinestablishing
afocusedopenHeartSurgeryprogrameinTrichy.Hehasrich
teachingexperienceandisanexaminerforB.P.T.(Bachelorin
Physiotherapy)courseformorethan12years.
MrsJeyantheiNarayanaswami(IndependentDirector)isa
qualifiedCompanySecretarywithover20yearsofpost-
qualificationexperience
Dr.SVijayabaskaran(Non-ExecutiveDirector)excelsinvarious
areas,likeProjectManagement,TurnaroundSpecialist/Mergers
&Acquisitions,BusinessDevelopment,andStakeholder
Management.BestIntegratedFarmingSystemResearch
Scientistfortheyear2013attheNationalLevel(ICAR).Best
ExtensionScientistfortheyear2008attheStatelevel.
11
Mr.SunilSatyapalGulati(IndependentDirector)isaB.Techdegreeholder
fromtheIIT,DelhiandaGoldMedalistfromtheIIMAhmedabad.HeisanIndependent
DirectorontheBoardofFedbankFinancialServicesLtdandSuryodaySmallFinance
BankLimited.HeholdsdirectorshipontheBoardofMerisisAdvisorsPvtLtd,SBI
MutualFundTrusteeCompanyPvtLtd,PerfiosAccountAggregationServicesPvtLtd,
AccessEquityPrivateLimited,TapstartCapitalPvtLtd&ArthanFinancePvtLtd.Heis
alsoamemberoftheMutualFundAdvisoryCommitteeconstitutedbySEBI.
Mr.P.Ravichandran(IndependentDirector)isaqualifiedElectronics&
CommunicationEngineerandhascompletedhismanagementeducation
programfromIIM,Ahmedabad.HehasparticipatedinStrategic
Leadership&InternationalBusinessProgramsinEuropeanBusiness
schoolsandExecutiveLeadershipProgramfromSingularityUniversity
California.HehasbeenassociatedwithDanfossgroupsince2002and
currentlyisthePresidentofDanfossIndustriesPvtLtd.
Mr.S.Mohan(IndependentDirector)isaqualifiedCharteredAccountant
practicingasapartnerofthefirm,PatelMohanRamesh&Cofor41Yrs.
PresentlyheisavicepresidentoftheSocietyofAuditors,Chennai.He
holdsdirectorshipintheboardofRelyonSoftechLimited,Bangaloreand
UnicorpAdvisorsPrivateLimited,Chennai
----------------Page (11) Break----------------
FY’2026 (Q4) PERFORMANCE SUMMARY
12
----------------Page (12) Break----------------
Q4 FY’2026 Performance Summary
Total Income
INR 84.2 Cr
Q4 FY’25
61.7 Cr36%
EBITDA and Margins %
INR 27.8 Cr
Margin: 33.0%
Q4 FY’25
16.2 Cr
Margin: 26.3%
71%
PAT and Margins %
Q4 FY’25
4.5 Cr
Margin: 7.3%
Occupied Bed Days
24,000
Q4 FY’25
19,38024%
Blended ARPOB
INR 32,838
7%
ALOS (days)
5.0
Q4 FY’25
4.76%
INR 14.6 Cr
Margin: 17.4%
13
225%
Q4 FY’25
30,586
----------------Page (13) Break----------------
Key operating metrics : Revenue & Profitability
Total Income (INR Cr)EBITDA (INR Cr & margin %)
Profit before tax (INR Cr & margin %)Profit after tax (INR Cr & margin %)
14
+36%+71%
26.3%31.1%33.0%
+124%
14.3%22.2%23.5%
+225%
7.3%16.5%17.4 %
4.5
13.714.6
Q4 F Y'25Q3 F Y'26Q4 F Y'26
8.8
18.519.8
Q4 F Y'25Q3 F Y'26Q4 F Y'26
16.2
25.927.8
Q4 F Y'25Q3 F Y'26Q4 F Y'26
61.7
83.284.2
Q4 F Y'25Q3 F Y'26Q4 F Y'26
----------------Page (14) Break----------------
330330330
215
270267
Q4 F Y'25Q3 F Y'26Q4 F Y'26
Census BedsOccupied Beds
Key operating metrics : Volumes, Occupancies & ALOS
Average census and occupied beds per day ALOS (days) (1)
OPD volumes (2)IPD volumes (3)
65%82%
1. ALOS is the average length of stay of patients in a specific period calculated as Census occupied beds days divided by In-patient volume 2. Out-patient volume refers to the total number of Out-patient
visits recorded in a specific period. 3. In-Patient volume refers to the total number of In-patient discharged in a specific period irrespective of admission date.
15
81%
+32%+17%
4.74.85.0
Q4 F Y'25Q3 F Y'26Q4 F Y'26
42,034
53,406 55,630
Q4 F Y'25Q3 F Y'26Q4 F Y'26
4,137
5,217 4,823
Q4 F Y'25Q3 F Y'26Q4 F Y'26
----------------Page (15) Break----------------
1.ARPP IP is calculated by In-patient Revenue divided by In-patient Nos 2. ARPP OP is calculated by Out-patient Revenue dividedby Out-patient Nos 3. Blended ARPOB is calculated by adding In-
patient & Out-patient Revenue divided by occupied bed days
Key operating metrics : ARPP, ARPOB & Revenue mix
Blended ARPOB (INR) (3)Revenue mix by payor category
Cash
TPA / Corporates
Govt. Scheme
ARPP IP (INR) (1)ARPP OP (INR) (2)
16
+13%+10%
+7%
1,18,182 1,22,660
1,33,895
Q4 F Y'25Q3 F Y'26Q4 F Y'26
2,470 2,642 2,716
Q4 F Y'25Q3 F Y'26Q4 F Y'26
30,586 31,481 32,838
Q4 F Y'25Q3 F Y'26Q4 F Y'269%9%7%
24%22%23%
67%69%70%
Q4 FY'25Q3 FY'26Q4 FY'26
----------------Page (16) Break----------------
Diverse Revenue Mix
Significant contribution from specialities
Neuro Science
Gastro Science
Critical Care
General Medicine
Plastic Surgery
Orthopaedics
Renal Science
Haematology
Others
Mother & child care Services*
*Mother & Child care Services include Neonataology, Obstetrics and Gynecand Pediatric services;
17
11%10%10%12%
3%3%3%3%
4%4%4%3%
6%6%7%6%
6%6%7%6%
7%7%6%7%
8%6%7%6%
12%12%13%12%
17%19%17%18%
26%27%25%27%
FY'25FY'26Q4 F Y'25Q4 F Y'26
----------------Page (17) Break----------------
Performance Highlights and Commentary
•TotalIncomehasincreasedbyINR22.4Cr.(36%)comparedtotheQ4previousyear;
•Thiswasachievedonthebackofstrong-performanceacrossofallourspecialtieswithincreasingtrendseen
involumesandrevenuemix;
•Consistentstrongperformanceof26%onTotalIncomeinQ4FY’26inourMotherandChildCareservices.
•TotalEBITDAearnedhasincreasedbyINR11.6Cr(71%)comparedtotheQ4previousyear;
•EBITDAasa%ofrevenueforQ4FY’26is33%ascomparedto26%intheQ4previousyear;
•PBT&PATasa%ofrevenueforQ4FY’26is23.5%&17.4%respectivelyascomparedto14.3%&7.3%in
theQ4previousyear.
18
----------------Page (18) Break----------------
Annexure: Profit & Loss Statement
19
Year endedQuarter ended
INR Cr FY'25 FY'26Y-o-Y Growth %Q4 FY'25Q3 FY'26Q4 FY'26Y-o-Y Growth %
Income
Revenue from operations 231.6 305.8 32.0% 60.9 82.1 82.3 35.0%
Other Income 3.1 5.1 64.5% 0.8 1.1 1.9 140.6%
Total Income 234.7 310.8 32.5% 61.7 83.2 84.2 36.3%
Cost of materials consumed 9.9 14.6 47.7% 3.1 3.8 4.031.1%
Purchase of traded goods 24.5 30.6 24.8% 6.6 7.8 8.731.9%
Changes in inventory of traded goods (0.8) (0.3)-67.2% (0.1) (0.1) (0.5)249.5%
Cost of Goods Sold33.7 45.0 33.7%9.5 11.4 12.2 28.2%
Employee benefits expense 51.9 65.8 26.8% 12.8 17.6 16.025.1%
Other Expenses 89.1 107.0 20.0% 23.3 28.3 28.221.4%
EBITDA 60.0 93.0 55.1% 16.2 25.9 27.8 71.4%
EBITDA Margins %25.6%29.9%26.3%31.1%33.0%
Finance costs 9.4 8.3 -11.8% 2.3 2.1 2.0 -12.2%
Depreciation and amortisation expense 19.0 21.7 14.3% 5.1 5.3 5.9 17.2%
PBT 31.6 63.0 99.4% 8.8 18.5 19.8 124.4%
PBT Margins %13.5%20.3%14.3%22.2%23.5%
Income tax expense 10.2 16.3 60.1% 4.3 4.7 5.2 20.2%
PAT 21.4 46.7 118.1% 4.5 13.7 14.6 223.5%
PAT Margins %9.1%15.0%7.3%16.5%17.4%
----------------Page (19) Break----------------
1. Networth at the end of FY’26 is INR 210.4 Cr
2.Total Borrowings (Term Loan + CC) at the end of FY’26 is INR 71.03 Cr ( which has been incurred for the New facility “Maa Kauvery”)
3.Total Cash Balance (including Fixed Deposit) at the end of FY’26 is INR 60.8 Cr and FY’25 is INR 17.5 Cr
Annexure: Balance Sheet
20
Equities & Liabilities (INR Cr)FY'26FY'25 Assets (INR Cr)FY'26FY'25
Total Equity 210.43 164.33 Non-Current Assets 250.91 252.76
Share Capital16.31 16.31 Property, Plant and Equipment235.10 239.69
Other Equity194.12 148.02 Right-of-Use-Assets12.34 7.56
Non-Current Liabilities 79.02 83.73 C WIP - -
Financial LiabilitiesInvestment Property0.40 0.40
(i) Borrowings61.43 72.33 Other Intangible assets0.03 0.04
(ii) Lease Liabilities9.78 5.52 Financial Assets
(iii) Other Financial Liabilities0.00- (i) Investments0.01 0.00
Deferred Tax Liabilities3.443.28 (ii) Loans - -
Other Non-Current Liabilities0.370.10 (iii) Other Financial Assets2.672.51
Provisions 4.00 2.50 Other Non-Current Assets (Net)0.372.55
Current Liabilities 42.67 37.94 Current Assets 81.21 33.24
Financial LiabilitiesInventories3.88 3.50
(i) Borrowings9.60 9.60 Financial Assets
(ii) Lease Liabilities2.87 2.00 (ii) Trade receivables7.35 5.98
(iii) Trade payables10.12 14.08 (ii) Cash and cash equivalents50.02 9.19
(iv) Other Financial Liabilities6.06 5.58 (iii) Bank Balances other than above4.67 0.15
Other Current Liabilities6.26 4.21 (iv) Loans0.29 0.26
Provisions 2.98 2.46 (v) Other Financial Assets11.98 12.64
Current Tax Liabilities (net)4.79Other Current Assets3.01 1.52
Total Equity & Liabilities 332.12 286.00 Total Assets 332.12 286.00
----------------Page (20) Break----------------
Annexure: Cash Flow Statement
Total Cash Balance (including Fixed Deposit) at the end of FY’26 is INR 60.8 Cr and FY’25 is INR 17.5 Cr
21
Particluars (INR Cr], FY26 FY'25
N-et Profit Befior,e, Tax
Ad. L!l st.me nt.s for: Non -Cash lt.e ms I Otih er I rnve st.me nt. or Financial lt.e ms
Ope,rati ng profit be,fior,e working ,ca pita I ,ch a ng,es
1[hang,es in Working Capital
r aoce s i( move me mt.)
N-et 1[ash from Ope,rating A,otiviti,es
N,et 1[a:sh from I nv,esti ng Activiti,es
N,et 1[a:sh from Financing A,ctiviti,es
N-et Increase, in Cash and 1[ ash E,q u iva l,ents
1[ash and 1[ash equival,ents at th,e beginning of the period
1[ ash and 1[ ash e,q u iva l,ents at the ,end of the period
163_1,2
28.19
91.21
.3.E2)
'87.1619
{8 .. 591)
79.11@1
1[1161. 9.3}
1(21 .. 34}
40JD
9.19
~0.112
.31 .ili@i
21.90
)9.~@i
4.82
164 . .33
i(6.14)
5758:
1[~0.94}
1~:2 .. 31@1}
4 .. 34
4.a,
9.19
kauvery
hospital
----------------Page (21) Break----------------
Annexure: Financial Ratios
22
1.NetDebtiscalculatedbyreducingCashandBankBalancesfromGrossDebt.
2.CurrentRatioiscalculatedbyincludingCapitalcreditors(currentliabilities)ofNewfacility“MaaKauvery”
Financial Ratios FY'26FY'25
Networth (INR Cr)210 164
Return on Capital Employed (%)25%17%
Return on Equity (%)22%13%
Debt Equity Ratio0.34 0.50
Net Debt / EBITDA (Times)0.11 1.07
Current Ratio (Times)1.9 0.9
DSCR (Times)5.1 3.2
Interest Coverage Ratio (Times)11.2 6.4
----------------Page (22) Break----------------
Annexure: Operational Parameters
23
Key Metrics FY'25 FY'26Y-o-Y Growth
%
Q4 FY'25Q3 FY'26Q4 FY'26Y-o-Y Growth
%
Census Beds330 330 0%330 330 330 0%
Occupied Beds 225 251 12%215 270 267 24%
Average Occupied Bed Days82,034 91,630 12%19,380 24,270 24,000 24%
Avg Occupancy Rate %68%76%65%82%81%
Blended ARPOB (INR)27,589 32,085 16%30,586 31,481 32,838 7%
ALOS (Days)5.24.9-6% 4.7 4.8 5.0 6%
In-Patient Volumes15,906 18,736 18%4,137 5,217 4,823 17%
Out-Patient Volumes1,55,815 1,99,099 28%42,034 53,406 55,630 32%
ARPP IP (INR)1,18,166 1,28,340 9%1,18,182 1,22,660 1,33,895 13%
ARPP OP (INR)2,462 2,689 9%2,470 2,642 2,716 10%
Quarter endedYear ended
----------------Page (23) Break----------------
HISTORICAL FINANCIAL PERFORMANCE
24
----------------Page (24) Break----------------
Key operating metrics : Revenue & Profitability
Total Income (INR Cr)EBITDA (INR Cr & margin %)
Profit before tax (INR Cr & margin %)Profit after tax (INR Cr & margin %)
25.6%24.1%28.4%28.0%
13.5%17.3%23.2%22.7%9.1%12.2%17.2%16.8%25
28.2%
22.4%16.8%
25.2
39.344.4
50.9
60.0
FY'21FY'22FY'23FY'24FY'25
18.0
32.1
36.0
40.6
31.6
FY'21FY'22FY'23FY'24FY'25
12.8
23.7
26.7
30.4
21.4
FY'21FY'22FY'23FY'24FY'25
----------------Page (25) Break----------------
1. ALOS is the average length of stay of patients in a specific period calculated as Census occupied beds days divided by In-patient volume 2. Out-patient volume refers to be total number of Out-patient
visits recorded in a specific period 3. In-Patient volume refers to the total number of In-patient discharged in a specific period irrespective of admission date.
Key operating metrics : Volumes, Occupancies & ALOS
Average census and occupied beds per dayALOS (days)(1)
OPD volumes (2)IPD volumes (3)
68%63%79%92%
26
94%
5.0
5.25.2
5.0
5.2
FY'21FY'22FY'23FY'24FY'25
77,066
94,766
1,09,082
1,24,318
1,55,815
FY'21FY'22FY'23FY'24FY'25
8,996
11,510
13,283 14,194
15,906
FY'21FY'22FY'23FY'24FY'25
----------------Page (26) Break----------------
Key operating metrics : ARPP & ARPOB
Blended ARPOB (INR) (3)
1.ARPP IP is calculated by In-patient Revenue divided by In-patient Nos 2. ARPP OP is calculated by Out-patient Revenue dividedby Out-patient Nos 3. Blended ARPOB is calculated by adding In-
patient & Out-patient Revenue divided by occupied bed days
ARPP IP (INR) (1)ARPP OP (INR) (2)
27
22,249 22,887 22,443
25,196
27,589
FY'21FY'22FY'23FY'24FY'25
91,108 99,113 98,262
1,05,724
1,18,166
FY'21FY'22FY'23FY'24FY'25
2,463
2,286
2,152
2,245
2,462
FY'21FY'22FY'23FY'24FY'25
----------------Page (27) Break----------------
Key operating metrics : ROCE & ROE
ROE (2)
1.ROCE is calculated as EBIT (Earnings before Interest and Tax) divided by capital employed (Shareholder’s equity plus long term borrowings) 2. ROE is calculated as PAT (Profit after Tax) divided by
``Shareholder’s Equity.
ROCE (1)
Note:
ROCE till FY’24 is calculated by excluding the Loan availed for New facility “Maa Kauvery”, which commenced its operations from
January 2024.
28
29%
37%
32%
29%
17%
FY'21FY'22FY'23FY'24FY'25
20%
27%
24%
21%
13%
FY'21FY'22FY'23FY'24FY'25
----------------Page (28) Break----------------
Annexures -Historical Profit and Loss Statement
29
INR CrFY'25FY'24FY'23FY'22FY'21
Income
Revenue from operations231.6177.2 155.8 136.1 102.6
Other income3.13.6 3.1 2.1 1.9
Total income234.7 180.7 158.9 138.2 104.6
Cost of materials consumed9.93.6 2.9 2.7 2.7
Purchase of traded goods24.520.7 20.4 17.9 13.5
Changes in inventory of traded goods(0.77) 0.2(0.31) (0.02) 0.2
Cost of Goods Sold 33.7 24.4 23.0 20.6 16.3
Employee benefits expense51.938.3 31.2 27.1 21.5
Other Expenses89.167.1 60.3 51.2 41.6
EBITDA 60.0 50.9 44.4 39.3 25.2
EBITDA Margins %25.6%28.2%28.0%28.4%24.1%
Finance costs9.41.16 0.8 0.7 1.0
Depreciation and amortisation expense19.09.22 7.6 6.5 6.2
PBT 31.6 40.6 36.0 32.1 18.0
PBT Margins %13.5%22.4%22.7%23.2%17.3%
Income tax expense10.210.2 9.3 8.4 5.3
P AT 21.4 30.4 26.7 23.7 12.8
PAT Margins %9.1%16.8%16.8%17.2%12.2%
----------------Page (29) Break----------------
Annexures -Historical Balance Sheet
30
Equities & Liabilities (INR Cr) FY'25FY'24FY'23FY'22FY'21Assets (INR Cr) FY'25FY'24FY'23FY'22FY'21
Total Equity 164.33 143.58 113.50 86.80 63.33 Non-Current Assets 252.76 230.20 129.80 86.29 78.86
Share Capital16.3116.31 16.31 16.31 16.31 Property, Plant and Equipment239.69195.55 78.36 72.53 71.16
Other Equity148.02127.27 97.19 70.49 47.02 Right-of-Use-Assets7.569.65 5.13 1.68 1.97
Non-Current Liabilities 83.73 73.68 45.61 22.45 29.11 C WIP0.000.64 34.04 5.64 1.61
Financial LiabilitiesInvestment Property0.400.40 0.40 0.40 0.40
(i) Borrowings72.3363.85 39.87 19.61 25.74 Other Intangible assets0.040.06 0.39 0.80 0.50
(ii) Lease Liabilities5.527.634.56 1.54 1.84 Financial Assets
(iii) Other Financial Liabilities0.000.00- - 0.12 (i) Investments0.000.00 0.00 0.00 0.00
Deferred Tax Liabilities3.280.64- 0.06 0.58 (ii) Loans0.000.00 - - 0.74
Other Non-Current Liabilities0.100.080.08 0.11 - (iii) Other Financial Assets2.514.261.77 1.08 0.02
Provisions 2.501.49 1.10 1.14 0.84 Other Non-Current Assets (Net)2.5519.629.71 4.14 2.45
Current Liabilities 37.94 46.45 22.54 19.51 12.55 Current Assets 33.24 33.52 51.86 42.48 26.13
Financial LiabilitiesInventories3.502.05 2.27 1.87 1.75
(i) Borrowings9.608.55 4.63 7.27 - Financial Assets
(ii) Lease Liabilities2.001.79 0.88 0.36 0.26 (ii) Trade receivables5.984.38 4.37 3.54 2.55
(iii) Trade payables14.087.56 6.41 5.41 5.21 (ii) Cash and cash equivalents9.194.85 1.84 1.67 2.13
(iv) Other Financial Liabilities5.5823.80 4.57 2.09 3.18 (iii) Bank Balances other than above0.1517.83 36.95 31.49 15.57
Other Current Liabilities4.212.93 3.16 2.29 2.31 (iv) Loans0.260.16 0.18 0.13 0.12
Provisions 2.461.82 2.89 2.08 1.60 (v) Other Financial Assets12.643.00 4.41 2.63 2.87
Other Current Assets1.521.25 1.83 1.15 1.13
Total Equity & Liabilities 286.00 263.72 181.65 128.76 104.99 Total Assets 286.00 263.72 181.65 128.76 104.99
----------------Page (30) Break----------------
Annexures -Historical Cash Flow Statement
31
Particluars (INR Cr) FY'25FY'24FY'23FY'22FY'21
Net Profit After Tax21.430.4 26.7 23.7 12.8
Adjustments for: Non -Cash Items / Other Investment or Financial Items 38.1 18.6 16.6 14.8 12.1
Operating profit before working capital changes 59.5 49.0 43.2 38.5 24.9
Changes in Working Capital 4.8 (0.4) (1.7) (0.2) 3.3
Cash generated from Operations 64.3 48.5 41.5 38.3 28.2
Direct taxes paid (net of fund)(6.7) (10.1) (9.2) (9.2) (2.6)
Net Cash from Operating Activities57.6 38.432.3 29.1 25.6
Net Cash from Investing Activities(50.9) (55.9) (48.0) (28.5) (42.6)
Net Cash from Financing Activities (2.3)20.5 15.8 (1.1) 18.0
Net Increase in Cash and Cash Equivalents 4.3 2.9 0.2 (0.5) 1.0
Cash and Cash equivalents at the beginning of the period 4.9 1.8 1.7 2.1 1.1
Cash and Cash equivalents at the end of the period 9.2 4.9 1.8 1.7 2.1
----------------Page (31) Break----------------
Annexure: Historical Operational Parameters
32
Key MetricsFY'25FY'24FY'23FY'22FY'21
Census Beds330205205205197
Occupied Beds 225193188163124
Average Occupied Bed Days 82,034 70,638 68,650 59,313 45,260
Avg Occupancy Rate %68%94%92%79%63%
Blended ARPOB (INR) 27,589 25,196 22,443 22,887 22,249
ALOS (Days)5.25.05.25.25.0
In-Patient Volumes 15,906 14,194 13,283 11,510 8,996
Out-Patient Volumes 1,55,815 1,24,318 1,09,082 94,766 77,066
ARPP IP (INR) 1,18,166 1,05,724 98,262 99,113 91,108
ARPP OP (INR) 2,462 2,245 2,152 2,286 2,463
----------------Page (32) Break----------------
THANK YOU
33
----------------Page (33) Break----------------
